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Summary
 
Exposure to maternal idiotypes (Ids) or antigens might predispose a child to develop an immu-
noregulated, asymptomatic clinical presentation of schistosomiasis. We have used an experi-
mental murine system to address the role of Ids in this immunoregulation. Sera from mice with
8-wk 
 
Schistosoma mansoni
 
 infection, chronic (20-wk infection) moderate splenomegaly syn-
drome (MSS), or chronic hypersplenomegaly syndrome (HSS) were passed over an 
 
S
 
.
 
 mansoni
 
soluble egg antigen (SEA) immunoaffinity column to prepare Ids (8WkId, MSS Id, HSS Id).
Newborn mice were injected with 8WkId, MSS Id, HSS Id, or normal mouse immunoglobu-
lin (NoMoIgG) and infected with 
 
S
 
.
 
 mansoni
 
 8 wk later. Mice exposed to 8WkId or MSS Id as
newborns had prolonged survival and decreased morbidity compared with mice that received
HSS Id or NoMoIgG. When stimulated with SEA, 8WkId, or MSS Id, spleen cells from mice
neonatally injected with 8WkId or MSS Id produced more interferon 
 
g
 
 than spleen cells from
mice neonatally injected with HSS Id or NoMoIgG. Furthermore, neonatal exposure to
8WkId or MSS Id, but not NoMoIgG or HSS Id, led to significantly smaller granuloma size
and lower hepatic fibrosis levels in infected mice. Together, these results indicate that perinatal
exposure to appropriate anti-SEA Ids induces long-term effects on survival, pathology, and im-
mune response patterns in mice subsequently infected with 
 
S. mansoni
 
.
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M
 
orbidity in human schistosomiasis is associated with
a failure to regulate immune responses to parasite
antigens. Individuals with the relatively asymptomatic “in-
testinal” chronic disease form have modulated responses to
schistosome soluble egg antigens (SEA),
 
1
 
 whereas individu-
als who eventually develop severe hepatosplenic disease
have unregulated responses to SEA (1). The factors that de-
termine whether patients demonstrate regulated (intestinal)
or unregulated (hepatosplenic) responses to parasite anti-
gens have not been definitively established. However, one
mechanism that has been associated with less severe mor-
bidity is the expression of certain cross-reactive, immuno-
regulatory idiotypes (Ids) on anti-SEA Abs (2). Affinity-
purified anti-SEA Abs prepared from sera of patients with
intestinal schistosomiasis contain Ids that stimulate PBMC
responses but those prepared from sera of hepatosplenic pa-
tients do not (2). Shared Ids among patients with intestinal
disease but not hepatosplenic patients are also demonstrable
by serologic cross-reactivity with antiidiotypic Abs (2, 3).
The immunoregulatory function of these cross-reactive Ids
(CRIs; reference 4) has been shown by their ability to
modulate granulomatous inflammation in an in vitro gran-
uloma model (5).
Previously, we have hypothesized that infection status of
the mother may determine whether or not individuals who
later become infected develop severe disease (1). Upon in-
fection, people born and raised in an area with a high prev-
 
1
 
Abbreviations used in this paper:
 
 CCA, circulating cathodic antigen; CRI,
 
cross-reactive Id; HSS, hypersplenomegaly syndrome; Id, idiotype;
MSS, moderate splenomegaly syndrome; NoHuIgG, normal human Ig;
NoMoIgG, normal mouse Ig; SEA, schistosome soluble egg antigen(s);
SWAP, schistosome adult worm antigenic preparation. 
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alence of schistosomiasis generally only develop the intesti-
nal form of chronic disease, with 
 
,
 
10% of these individuals
progressing to hepatosplenic disease. In contrast, travelers
or recent immigrants to an endemic area often present with
acute illness, ectopic infection, and/or severe disease if they
become infected (6, 7). Age/prevalence and age/intensity
curves predict that many of the mothers of people living in
endemic areas are likely to have had schistosomiasis at the
time they were pregnant with and gave birth to their chil-
dren. In contrast, mothers of travelers or immigrants to an
endemic area would not have had schistosomiasis. Evi-
dence for an immunologic contribution to this observation
comes from studies demonstrating that cord blood cells
from children born to infected mothers respond to Id pre-
pared from their mother’s serum or from the sera of an in-
testinal patient pool. Cord blood cells from children born
to mothers who did not have schistosomiasis did not re-
spond to these Ids (8).
To better understand how neonatal Id exposure affects
eventual immune responses and pathology after subsequent
infection, we have used a murine model of chronic infec-
tion that closely parallels human pathologic and immuno-
logic presentations. Inbred male CBA/J mice with 20-wk
 
Schistosoma mansoni 
 
infections present with one of two dis-
tinct pathologic syndromes: moderate splenomegaly syn-
drome (MSS) or hypersplenomegaly syndrome (HSS) (9,
10). HSS affects 
 
z
 
20% of the chronically infected mice and
is characterized by massive splenomegaly, ascites, thymic
atrophy, severe anemia, and cachexia. The histopathologic
features of the HSS syndrome are splenic congestion,
lymph node plasmacytosis, and extensive periportal-like
liver fibrosis. The remaining majority of mice have MSS
chronic infections and develop only moderate splenomegaly.
The clinical and pathologic characteristics of MSS and HSS
mice closely parallel those features of schistosomiasis patients
with the intestinal and hepatosplenic disease forms, re-
spectively. In addition, the parallel mouse and human forms
(MSS with intestinal and HSS with hepatosplenic) share
idiotypic repertoires on their anti-SEA Abs as shown by
cross-reactivity with antiidiotypic Abs (9) as well as T lym-
phocyte response patterns (11). Like Id from intestinal pa-
tients’ sera that can stimulate proliferation of peripheral
blood T lymphocytes from schistosomiasis patients, Id
preparations from 8 wk–infected mouse sera (8WkId) or
MSS mouse sera (MSS Id) are stimulatory for spleen cells
from 
 
S
 
.
 
 mansoni
 
–infected mice. HSS mice Id preparations,
like hepatosplenic human Id preparations, are not stimula-
tory (2, 11).
To study the influence of perinatal idiotypic exposure on
subsequent immunologic responses and development of
pathology, morbidity, and mortality, newborn mice were
exposed to anti-SEA Abs (Id preparations) from various
sources and were subsequently (8 wk later) infected with 
 
S
 
.
 
mansoni
 
. The prolonged survival, the enhanced production
of IFN-
 
g
 
, and the downregulation of granuloma formation
seen after neonatal exposure to 8WkId or MSS Id suggest
that such exposure to CRIs (4) is beneficial during subse-
quent 
 
S
 
.
 
 mansoni
 
 infections.
 
Materials and Methods
 
Animals, Neonatal Exposure, and Infections.
 
CBA/J mice were
obtained from The Jackson Laboratory and housed in the Ameri-
can Association for Accreditation of Laboratory Animal Care–
approved animal care facilities of the Centers for Disease Control
and Prevention. Newborn (
 
,
 
24 h old) male mice from unin-
fected parents received transthoracic, intraperitoneal injections of
50 
 
m
 
g of immunoaffinity-purified anti-SEA Abs, commercial
normal mouse IgG (NoMoIgG; Sigma), human anti-SEA mAb
E5 (12), or commercial normal human IgG (NoHuIgG; Sigma)
in PBS. To prepare affinity-purified, polyclonal anti-SEA Abs,
pooled sera from mice infected for either 8 or 20 wk (the latter
segregated into MSS and HSS) were passed over a column of
SEA coupled to cyanogen-bromide–activated Sepharose 4B
(Sigma). Bound anti-SEA Abs (Id) were eluted using 0.1 M gly-
cine-HCl (pH 2.8) and collected into 0.025 M borax. The elu-
ates were concentrated and dialyzed against saline, and their pro-
tein concentrations were determined. All Id preparations (i.e.,
those from different serum sources) used in a given experiment
were prepared over the same column. Mice that had been neona-
tally manipulated were infected at 8 wk of age by subcutaneous
injection of 45 cercariae of a Puerto Rican strain of 
 
S. mansoni
 
that had been maintained in 
 
Biomphalaria glabrata
 
 snails. The
number of live animals was recorded weekly to give survival pro-
portions.
 
Circulating Antigen Detection and Enumeration of Eggs in the Liver.
 
Levels of adult worm circulating cathodic antigen (CCA) were
quantified in the sera from infected mice using the 5H11 mono-
clonal sandwich assay as described previously (13). Absorbance
levels from serum samples were compared with those obtained
on an adult schistosome worm antigenic preparation (SWAP)
standard curve run in parallel to obtain a SWAP equivalent that
could be used to compare results from samples run on different
days.
For enumeration of eggs in the liver, a portion (
 
z
 
0.5 g) of
weighed liver from infected mice was removed and frozen until
digestion. For digestion, 5 ml of 5% KOH (14) was added to each
tube and incubated at 37
 
8
 
C until the tissue was completely di-
gested (2–4 h). Duplicate 25-
 
m
 
l aliquots of the digest were placed
on a glass slide, and eggs were counted under microscope. Data
are expressed as eggs per gram of liver tissue.
 
Determination of Anti-SEA Ab Isotypes.
 
Ab isotype analyses
were performed by specific ELISAs to detect anti-SEA activity
and to evaluate what effects the cytokine environment may have
on Ab class switching in these animals (15, 16). SEA (0.25 
 
m
 
g/
well in 0.1 M NaHCO
 
3
 
, pH 9.6) was adsorbed onto flat-bot-
tomed microtiter plates (Immunolon II; Dynatech Laboratories,
Inc.) overnight, at 4
 
8
 
C. After a 1-h blocking step of PBS with
0.3% Tween 20 (Sigma), plates were incubated with optimized
dilutions of infected mouse sera. Anti-SEA Abs bound to the
SEA-coated plate were detected using peroxidase-conjugated
IgG fractions of isotype-specific goat anti–mouse IgG1, anti–
mouse IgG2a, or anti–mouse IgG2b (Southern Biotechnology
Associates, Inc.). Assays were developed by the addition of TMB
peroxidase substrate solution (Kirkegaard & Perry Laboratories),
the reaction was halted by addition of 1 M H
 
2
 
SO
 
4
 
, and the color
reaction was read at 450 nm on a microplate reader (Molecular
Devices Corp.).
 
Cytokine Production and Measurement.
 
Spleen cells were cul-
tured in 48-well plates (Costar Corp.) at 2.5 
 
3 
 
10
 
6
 
 cells/well in 1
ml RPMI 1640 supplemented with 2% fetal bovine serum and
2% penicillin/streptomycin (GIBCO BRL). Cultures were main-
tained at 37
 
8
 
C in a humidified atmosphere with 5% CO
 
2
 
 and 
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stimulated with medium alone, SEA (4 
 
m
 
g/ml), or anti-SEA Id
preparations (40 
 
m
 
g/ml). Supernatant fluids were harvested after
48 h and stored at 
 
2
 
70
 
8
 
C. Cytokine levels were measured by
capture ELISA as described previously (11).
 
Preparation of Tissue for Microscopic Examination.
 
Upon killing
of the experimental animals, livers were removed and a portion
of each liver was preserved in 10% buffered formalin. For histo-
logic analysis, tissues were imbedded in paraffin, sectioned (5 
 
m
 
m),
and stained with hematoxylin and eosin. Granuloma areas were
measured with the aid of computerized morphometrics (Im-
agePro Plus; Media Cybernetics). Only those granulomas with a
single, central egg were measured. Granulomas containing more
than one egg or that were contiguous with other granulomas
were ignored. A minimum of 25 granulomas was measured per
mouse to calculate the average granuloma size for individual
mice. The means for all mice in each group were then averaged
for statistical comparison of the groups. For evaluation of fibrosis,
some liver sections were stained with Gomori’s trichrome stain.
Computerized morphometrics were used to calculate the percent
fibrotic area of 25 contiguous fields, and the average fibrotic tis-
sue area was calculated for each mouse. As with the granuloma
measurements, the means for each mouse in a group were aver-
aged for statistical comparison.
 
Statistical Analyses.
 
Statistical analyses were performed using
Instat and Prism software (GraphPad Software for Science).
Group means were compared by two-tailed 
 
t
 
 test for comparison
of two groups; two-tailed analysis of variance and multiple com-
parison tests were used for comparison of three or more groups.
Statistical analyses of survival proportions were performed using
two-tailed log–rank tests and two-sided Fisher’s exact test.
 
 P 
 
val-
ues 
 
,
 
0.05 were considered to be statistically significant.
 
Results
 
Neonatal Exposure to 8WkId or MSS Id Leads to Prolonged
Survival of Mice Subsequently Infected with S. mansoni.
 
To
determine the long-term effects of neonatal exposure to Id,
we monitored the survival of chronically infected mice for
20 wk of infection. Mice were injected with 50 
 
m
 
g of dif-
ferent Id preparations within the first 24 h of life and then
infected with 45 cercariae when they became adults. There
were no deaths in any group before 8 wk of infection.
Mice that received 8WkId lived significantly longer (
 
P
 
 
 
,
 
0.05) than mice that received NoMoIgG (Fig. 1, top and
middle). A similar, significant prolongation of survival was
also observed after neonatal injection of MSS Id compared
with NoMoIgG or HSS Id (Fig. 1, middle and bottom). All
mice that had received 8WkId or MSS Id displayed the less
severe characteristics of MSS at 20 wk of infection. The
percent survival at 20 wk for each of these experiments is
shown in Table I. Interestingly, the mice that received HSS
Id showed decreased survival proportions compared not
only with 8WkId- and MSS Id–injected animals (
 
P
 
 
 
,
 
0.0001) but also with animals that received NoMoIgG
(
 
P
 
 
 
, 
 
0.002).
Although 8WkId, MSS Id, and HSS Id were all prepared
on the same SEA-Sepharose column, we also tested sur-
vival of 
 
S
 
.
 
 mansoni
 
–infected mice injected neonatally with
an mAb (E5) to counter the possibility that the effects ob-
served in the survival studies were a consequence of SEA
that had leached off the affinity column into the Id prepara-
tions. E5 was produced from a human heterohybridoma
that shares CRIs with 8WkId and MSS Id (9, 12, 17). Be-
cause this Ab was not passed over the SEA affinity column,
there is no chance that the preparation was contaminated
with SEA. As with the polyclonal 8WkId or MSS Id prep-
arations, neonatal exposure to E5 resulted in longer survival
times than for mice that received NoHuIgG (Fig. 2).
 
Downregulation of Granulomas and Fibrosis 8 wk after Infec-
tion as a Result of Neonatal Exposure to 8WkId or MSS Id.
 
We next analyzed the histopathological features of mice
that were neonatally exposed to NoMoIgG, 8WkId, MSS
Id, or HSS Id preparations and subsequently infected with
 
S. mansoni
 
. Mice that received 8WkId or MSS Id as new-
borns had a significantly smaller acute (8 wk) infection
mean granuloma size (Fig. 3 A) and a significantly de-
Figure 1. Neonatal injection of mice with CRI (8WkId or MSS Id)
confers increased survival upon subsequent S. mansoni infection. Mice
neonatally injected with 8WkId, MSS Id, HSS Id, or NoMoIgG were in-
fected at 8 wk of age and monitored for survival over the next 20 wk of
infection. The neonatal injection is indicated in the key for each experi-
ment, and the initial number of mice is shown in parentheses. 
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creased percentage of fibrotic liver tissue at 8 wk after in-
fection (Fig. 3 B) than mice that received NoMoIgG or
HSS Id at birth. The histologic appearance of granulomas
and fibrotic areas representative of these means is presented
in Fig. 4. We also observed that mice receiving 8WkId or
MSS Id at birth had decreased 8 wk–infection spleen to
body weight ratios than animals neonatally injected with
NoMoIgG or HSS Id (Table II). To determine whether
these differences in pathology were simply an effect of dif-
ferences in worm burdens, we measured CCA levels in
these animals but found no significant difference between
mice in any of the neonatal injection groups (Table II).
However, in spite of the comparable worm burdens, mice
that received HSS Id as newborns were found to have a
significantly higher mean number of eggs per gram of liver
than mice that had been injected with MSS Id (Table II),
resulting in the fibrosis per egg between these two groups
not being significantly different (data not shown). The
numbers of eggs per gram of liver for mice neonatally in-
jected with NoMoIgG or 8WkId were not significantly
different from each other or from either the MSS Id or
HSS Id injection groups (Table II).
 
Mice Neonatally Injected with 8WkId or MSS Id Present
Distinct Cytokine Response Profiles at 8 wk of Infection.
 
To
study whether neonatal exposure to Id has an effect on cy-
tokine profiles expressed in response to SEA or Id (11) dur-
ing subsequent 
 
S. mansoni
 
 infections, spleen cells were har-
vested from 8 wk–infected mice that had been exposed to
the different Id preparations 16 wk previously, as new-
Figure 2. Neonatal injection of mice with a CRI-expressing human
mAb (E5) confers increased survival upon subsequent S. mansoni infec-
tion. Mice neonatally injected with E5 or NoHuIgG were infected at 8 wk
of age and monitored for survival over the next 20 wk of infection. The
neonatal injection is indicated in the key, and the initial number of mice
is shown in parentheses.
 
Table I.
 
Percent Survival at 20 wk
 
Neonatal injection
NoMoIgG 8WkId MSS Id HSS Id
Experiment 1 41% (7/17) 62% (18/29) — —
Experiment 2 15% (2/13) 35% (5/14) 58% (7/12) 0% (0/13)
Experiment 3 15% (2/13) — 46% (7/15) 0% (0/18)
Summary 25% (11/43)
 
*
 
53% (23/43)
 
‡
 
52% (14/27)
 
‡
 
0% (0/31)
 
*
 
P
 
 
 
5
 
 0.002 compared with HSS Id–injected group.
 
‡
 
P
 
 
 
, 
 
0.0001 compared with NoMoIgG- or HSS Id–injected groups.
Figure 3. Granulomatous response and liver fibrosis are decreased in
mice infected for 8 wk that received MSS Id at birth. Neonatal mice were
injected with NoMoIgG (n 5 20), 8WkId (n 5 19), MSS Id (n 5 14), or
HSS Id (n 5 14) and infected with S. mansoni at 8 wk of age. At 8 wk af-
ter infection, livers were harvested and processed for histology. Animals
that had received 8WkId or MSS Id at birth had significantly smaller
granulomas (A) and significantly decreased liver fibrosis (B) than animals
neonatally injected with NoMoIgG or HSS Id (*P , 0.01). 
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borns. The spleen cells were stimulated with SEA or Id
preparations, and the supernatants were assayed for cyto-
kines. Spleen cells from mice infected for 8 wk that had re-
ceived 8WkId or MSS Id as newborns produced higher
levels of IFN-
 
g
 
 in response to SEA or stimulatory Id prep-
arations (8WkId or MSS Id) than did spleen cells from mice
neonatally exposed to NoMoIgG or HSS Id (Fig. 5). Con-
sistent with previous results (11), and similar to anti-SEA Id
preparations from hepatosplenic patients (2), HSS Id was
not stimulatory for any of the measured responses for cells
from any treatment group.
Because isotype switching to IgG2a in mice is at least in
part effected by IFN-
 
g
 
 (15, 16), we investigated the anti-
SEA IgG subclasses present in sera of the neonatally manip-
ulated mice (Fig. 6). At 8 wk of infection, SEA- and
SWAP-specific IgG2a and IgG2b levels in sera of mice
neonatally injected with 8WkId or MSS Id
 
 
 
were higher
than those of mice neonatally injected with NoMoIgG or
HSS Id (
 
P
 
 
 
, 
 
0.0001). SEA- and SWAP-specific IgG1 lev-
els were similar among the various neonatal injection
groups, indicating that the differences in granuloma and fi-
brotic regulation were not related to a failure to make
schistosome-specific Abs in mice neonatally treated with
NoMoIgG or HSS Id.
 
Discussion
 
Many studies on different human parasitic diseases have
shown an effect of maternal infection status on immune re-
sponses in the cord blood or early life of the child (8, 18–
Figure 4. Photomicrographs of granulomas (A and B; hematoxylin and eosin staining) and fibrotic tissue (C and D; Gomori’s trichrome staining) rep-
resentative of the group means of animals neonatally injected with MSS Id (A and C) or HSS Id (B and D). Original magnification: 3200; bars, 50 mm.
Blue staining in C and D is indicative of fibrosis, some of which is periportal in HSS Id–injected animals (D).
Table II. Comparison of Percentage of Spleen Weight/Body 
Weight, Levels of CCA, and No. of Eggs/Liver in 8 wk–infected 
Mice that Were Neonatally Exposed to MSS Id or HSS Id
Neonatal
injection
Spleen wt/
body wt CCA Eggs/liver
3100
NoMoIgG 0.850 6 0.039* 10.23 6 2.47 5,283 6 708
8WkId 0.568 6 0.029 13.68 6 4.18 3,967 6 565
MSS Id 0.537 6 0.031 14.32 6 7.48 3,061 6 641
HSS Id 1.244 6 0.059* 8.71 6 3.50 6,268 6 751‡
Data are presented as mean 6 SEM.
*P , 0.001 compared with other three groups.
‡P , 0.01 compared with MSS Id–injected group.642 Neonatal Id Exposure Decreases Pathology in Experimental Schistosomiasis
24). In addition, two field site revisitation studies have
shown that these effects on the immune system can persist
for up to 20 yr (25, 26). However, due to ethical and logis-
tical limitations, it has not been possible to study whether
maternal infection status alters a child’s long-term pathol-
ogy in these chronic infections. Therefore, most of the evi-
dence for maternal infection status (i.e., perinatal exposure
to parasite-related stimuli) having a beneficial effect on sub-
sequent clinical form of disease is anecdotal.
This study examines a possible role of maternal idiotypic
interactions in experimental S. mansoni infections using id-
iotypic manipulations of the neonatal immune system.
Mice that received appropriate Id injections during the first
24 h of life displayed altered immune responses, decreased
pathology, and increased long-term survival upon infection
with schistosomiasis. The reduced pathology observed in
mice neonatally injected with Ab preparations that express
CRI (8WkId or MSS Id) was associated with a Th1-type
response. These animals demonstrated increased produc-
tion of IFN-g by spleen cells stimulated with either SEA or
CRI compared with animals that received no Id injection,
NoMoIgG, or HSS Id during the first 24 h of life. Mice
that received 8WkId or MSS Id also had higher levels of
the IFN-g–associated Ab isotypes (IgG2a/b) specific for
schistosome antigens than did mice neonatally injected
with NoMoIgG or HSS Id, but all groups had similar levels
of SEA- and SWAP-specific IgG1. These data are consis-
tent with previous findings that demonstrate a role (27–29),
albeit not a requirement (30), for IFN-g in the regulation
of granuloma size and fibrotic pathology in schistosome-
infected mice.
CCA levels, which reflect relative adult worm burden
(13), were similar among all groups of mice. This demon-
strates that the observed beneficial effects of appropriate
neonatal Id injection are not explained by differences in in-
fection level. We did find that the number of parasite eggs
in the livers of animals neonatally injected with HSS Id
were significantly higher at 8 wk of infection than in mice
neonatally injected with MSS Id. This could be related to
the observation that TNF-a potentiates egg production by
female worms (31) and our previous observation (32) that
TNF-a levels are dramatically elevated in HSS mice.
When we divided the relative fibrotic area by the number
of eggs in the livers, we did not see a significant difference
between the amount of fibrosis per egg between groups,
and therefore it is possible that the increased egg burden
contributes directly to host mortality. Nevertheless, this
difference is still determined by idiotypic manipulations
at birth. Furthermore, we observed a difference in patterns
of fibrosis in the different groups, as the livers from
NoMoIgG- or HSS Id–injected animals demonstrated areas
of periportal fibrosis whereas the fibrosis in the livers of
8WkId- or MSS Id–injected animals was only associated
with eggs in granulomas. Also, animals that received CRI
Figure 5. Neonatal exposure to 8WkId or MSS Id induces enhanced
IFN-g production during subsequent infection. Newborn mice (,24 h
old) were injected with 50 mg of NoMoIgG, 8WkId, MSS Id, or HSS Id.
At 8 wk of age, animals were infected with S. mansoni. At 8 wk after in-
fection, spleen cells were harvested and stimulated with SEA (4 mg/ml),
8WkId (40 mg/ml), MSS Id (40 mg/ml), or HSS Id (40 mg/ml). Data
represent means of IFN-g levels in 48-h supernatants minus unstimulated
control values. The n values listed in the key indicate the number of mice
per group. Spleen cells from animals neonatally injected with 8WkId or
MSS Id produced significantly higher levels of IFN-g (*P , 0.01) than
infected animals receiving NoMoIgG or HSS Id at birth when later stim-
ulated with SEA, 8WkId, or MSS Id.
Figure 6. Mice neonatally injected with CRI (8WkId or MSS Id) pro-
duce elevated levels of SEA- and SWAP-specific IgG2a or IgG2b at 8 wk
of infection. The sera of the mice neonatally injected with Id, infected at
8 wk of age, and killed at 8 wk after infection were screened for specific
isotype responses to SEA (A) and SWAP (B). Mice that received 8WkId
or MSS Id as neonates had significantly higher levels of antigen-specific
IgG2a and IgG2b than mice that were injected with NoMoIgG or HSS
Id at birth (*P , 0.001).643 Montesano et al.
as neonates demonstrated significantly less splenomegaly
compared with animals injected with NoMoIgG or HSS Id
at birth. Although it is not clear whether the decreased
mortality in CRI-treated animals is related to the overall
level of fibrosis, a difference in distribution of fibrosis, or
decreased fibrosis subsequent to fewer eggs in the liver, it is
apparent that the differences are related to the neonatal Id
treatment and not a result of differences in the infection
levels of these animals. The direct cause of mortality is be-
ing addressed in ongoing studies.
One common criticism of work using affinity-purified
Abs is that antigen has leached from the column and the
suggested effect of Ab is actually an effect of the leached
antigen. We are confident that Id, and not leached antigen,
is the important component of the neonatal injection for a
variety of reasons. First, all Id preparations for a given ex-
periment were made using the same SEA affinity column.
If SEA were leaching off of the column and were the “ac-
tive” component in the neonatal Id injections, there would
be no differences between the effects observed between
HSS Id and MSS Id or 8WkId injections. Second, mice
injected with MSS Id or 8WkId, but not HSS Id or
NoMoIgG, within the first 24 h of life have CRI and anti-
CRI present in their sera at 8 wk of life, even in the ab-
sence of subsequent infection or exposure to schistosome
antigens (our manuscript in preparation). These levels of
CRI far exceed the amount of CRI initially injected (and
that would have decayed by this time; reference 33) and in-
dicate that neonatal Id injection induces animals to produce
Id. Finally, work by Hang et al. (34) demonstrated that
neonatal injections of SEA were ineffective at altering sub-
sequent immune responses to schistosome infection unless
at least 600–900 mg SEA were injected. Therefore, even
if a small amount of SEA (which is undetectable on sil-
ver-stained gels of Id preparations [35]) did leach from the
affinity column, it would not be sufficient to confer the
results observed in these studies. Furthermore, a similar sur-
vival curve as seen with 8WkId and MSS Id was obtained
using the CRI-expressing mAb, E5 (9, 12, 17).
Recent studies by Jankovic et al. (36) have also indicated
a role for Ab in the immunoregulation of morbidity and
mortality during experimental schistosomiasis. Mice lack-
ing B cells exhibited decreased granuloma modulation and
increased mortality compared with wild-type controls (36).
FcgR knockout mice also exhibited decreased granuloma
modulation (but no increase in mortality) upon infection,
suggesting an essential role for FcR signaling in granuloma
modulation (36). Our studies indicate that not every schis-
tosome-reactive Ab is sufficient to initiate regulatory re-
sponses, but that specific antischistosome Ids on certain
anti-SEA Abs are required for the development of the im-
munoregulation of disease and protection from mortality
during schistosomiasis. For example, HSS Id and sera from
animals with HSS have strong reactivity to SEA (11; Fig. 6)
but lack the CRI found in MSS Id or sera from MSS Id–
infected animals (9). Not only do neonatal HSS Id injec-
tions fail to confer the immunoregulation and enhanced
survival conferred by neonatal exposure to MSS Id or
8WkId, but animals neonatally injected with HSS Id actu-
ally have a significantly decreased survival proportion com-
pared with mice that received NoMoIgG at birth (Fig. 1,
middle and bottom). This result suggests the interesting
possibility that in addition to idiotypic specificities that are
beneficial for host immunoregulation of disease, there may
also be other anti-SEA idiotypic specificities that promote
morbidity and mortality.
Based on proliferative and cytokine responses of spleen
cells to MSS Id but not HSS Id (11), we believe that Id is
effecting responses through cross-linkage of T cell recep-
tors. Although we have yet to directly demonstrate this in
mice, studies on idiotypic stimulation of PBMCs from
schistosomiasis patients suggest that this is the case (35, 37).
Soluble, divalent whole Id or F(ab9)2 fragments of Id stimu-
late T cell proliferation, but monovalent Id Fabs do not un-
less they are covalently bound to a solid support. Processing
by APCs is not required, and the need for adherent acces-
sory cells can be overcome if IL-1 is provided (35, 37). The
contention that the Id effect is receptor mediated is also
supported by many similar studies demonstrating that even
one low level perinatal exposure to Id-expressing Abs and/or
anti-Id Abs profoundly alters the generation of B and T cell
repertoires expressed later in life (38–48).
In most areas endemic for schistosomiasis, the majority
of people infected with schistosomes were born of mothers
that had schistosomiasis (1). Furthermore, few individuals
born and raised in such areas exhibit acute, symptomatic
disease upon their early schistosome infections, and only
5–8% go on to develop severe chronic disease. Based on
the Id/anti-Id interactions reported here and observations
in endemic areas, it might be fruitful to examine the possi-
bility of these circumstances and their effects in a variety of
chronic infections that exhibit endemicity and high preva-
lence in the child-bearing years (1).
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